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Abstract
Recent guidelines on cardiovascular disease prevention suggest
multimodal behavioral interventions for psychosocial risk factors and
referral for psychotherapy in the case of clinically significant symptoms
of depression and anxiety overall. Accordingly, psychologists of the
Italian Association for Cardiovascular Prevention, Rehabilitation and
Epidemiology (GICR-IACPR) have reviewed the key components of psy-
chological activities in cardiovascular prevention and rehabilitation
(CPR). The aim of this study was to elaborate a position paper on the
best practice in routine psychological activities in CPR based on effi-
cacy, effectiveness and sustainability.
The steps followed were: i) a review of the latest international guide-
lines and position papers; ii) analysis of the evidence-based literature; iii)
a qualitative analysis of the psychological services operating in some ref-
erence Italian cardiac rehabilitation facilities; iv) classification of the psy-
chological activities in CPR as low or high intensity based on the NICE
Guidelines on psychological interventions on anxiety and depression.
We confirm the existence of an association between depression, anx-
iety, social factors, stress, personality and illness onset/outcome and
coronary heart disease. Evidence for an association between depression,
social factors and disease outcome emerges particularly for chronic heart
failure. Some positive psychological variables (e.g., optimism) are asso-
ciated to illness outcome. Evidence is reported on the impact of psycho-
logical activities on ‘new’ conditions which are now indicated for cardiac
rehabilitation: pulmonary hypertension, grown-up congenital heart, end-
stage heart failure, implantable cardioverter-defribrillator and mechan-
ical ventricular assist devices, frail and oldest-old patients, and end-of-
life care. We also report evidence related to caregivers. The Panel divided
evidence-based psychological interventions into: i) low intensity (coun-
seling, psycho-education, self-care, self-management, telemedicine, self-
help); or ii) high intensity (individual, couples and/or family and group
psychotherapy, such as stress management). The results show that psy-
chotherapy is consisting of cognitive-behavioral therapy (mainly), inter-
personal therapy, and short term psycho-dinamic therapy.
The current data further refine the working tools available for psycho-
logical activities in CPR, giving clear directions about the choice of in-
terventions, which should be evidence-based and have at least a min-
imum standard. This document provides a comprehensive update on new
knowledge and new paths for psychologists working in the CPR settings.
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chological evaluation and eventual monitoring over time; the second
consists of low-intensity interventions suitable for patients with less
severe disorders and/or of recent onset, such as education, coun-
seling, relaxation techniques, and self-help groups; the third provides
for more severe patients with high-intensity interventions, mainly
psychotherapeutic treatments. The extensive and now widespread ap-
plication of the IAPT model has confirmed its appropriateness, effec-
tiveness and efficiency [14-16].
The low/high intensity classification allows the psychologist to iden-
tify and select, based on scientific evidence, interventions that can be
adapted to different patients, different organizational regimes (hospi-
talization, day hospital, outpatient) and to the time available (full-time,
part-time, or consultant psychologist). The IAPT treatment pathway is
self-correcting in the sense that, if a patient with sub-threshold symp-
toms deteriorates over time or does not gain benefit from low-intensity
treatments, he/she will go on to high-intensity treatments.
Methods
The criteria used to elaborate this position paper on best practice
were based on:
• consultation of the latest international guidelines and consensus
statements produced by the major scientific societies;
• identification of a reference bibliography based on evidence of ef-
fectiveness through a search of the most well-known databases
(Cochrane Library, Medline, PsychINFO [2005-2017];
• qualitative analysis of the psychological services offered in some
reference cardiac rehabilitation facilities.
We did not examine in this document the psychological approach
and treatments for addictions and sexuality, for which the reader
should refer to the relative guidelines.
In presenting the evidence for the association between psychological
variables and disease manifestation/outcome and/or for the association
between psychological variables and clinical condition, the strength of ev-
idence is graded as strong, moderate, or mild. “Onset” of a disease is de-
fined as its occurrence, while the term ‘outcome’ refers to its clinical
trend (new events, mortality). For each pathology, after a brief discussion,
we provide a synthesis of the evidence of the associations between psy-
chological variables and disease and of the psychological interventions.
The evidence-based interventions are divided into two levels ac-
cording to the NICE model [10] (Table 1).
Introduction
The aim of this position paper is to serve as a tool for consultation in
order to promote best practice (based on effectiveness, efficiency and
sustainability) in the daily clinical activity of psychologists working in
the Cardiovascular Prevention and Rehabilitation (CPR) setting. Since
the publication in 2003 of the “Guidelines for psychology activities in
cardiologic rehabilitation and prevention” [1] there has been a con-
stant growth both in the number of psychological interventions per-
formed in the real-world of CPR [2] and in the publication of articles,
meta-analyses and systematic reviews [3-8] on the association be-
tween heart disease, psychological variables and psychological inter-
ventions. Therefore, the need has emerged to update the knowledge
not only as regards the traditional indications for CPR interventions -
coronary heart disease (CHD), chronic heart failure (CHF) and cardiac
surgery - but also concerning psychological activities in other scenarios
of cardiovascular disease (CVD) where the indication for rehabilitation
treatment has emerged more recently, such as pulmonary hyperten-
sion, grown-up congenital heart (GUCH), end-stage heart failure, use
of implantable cardioverter-defribrillator and mechanical ventricular
assist devices, frail and older/oldest patients, and end-of-life care. This
document also includes an analysis of family/caregivers and their spe-
cific need for psychological interventions: in fact, numerous reports in
the literature [9] now show the positive effects of good family and so-
cial support on CVD outcome in terms of better adherence and reduced
readmissions, particularly in elderly patients who are increasingly re-
ferred to CPR programs and for whom the importance of a neuropsy-
chological evaluation is also stressed.
A special feature of this paper is the introduction of a low/high in-
tensity grade for classifying the psychological interventions, in line
with the NICE guidelines on psychological interventions for anxiety
and depression disorders [10]. In the nineties, in fact, the “stepped
care” model was introduced [11] which envisaged the planning of
clinical psychology and psychotherapy interventions at different
levels of intensity and complexity (low or high) according to the re-
sults of the initial assessments carried out [12]. In 2007, the British
government approved the “Improving Access to Psychological Thera-
pies” (IAPT) Program [13] to facilitate the access of people with
common emotional disorders to evidence-based psychological treat-
ments (Care Services Improvement Partnership, 2007). This program
is characterized by three steps, the first of which is related to psy-
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Table 1. Evidence based interventions divided into two levels according to the NICE model.
Low intensity = interventions of low complexity performed by the psychologist and/or in collaboration 
with the multidisciplinary team:
• Individual and/or group counseling (from single interview to motivational interview)
• Psycho-educational sessions regarding psychosocial risk factors, smoking, diet, etc.
• Multidisciplinary sessions regarding information and management (self-care, self-management, self-help)
• Self-help groups
• Use of self-help manuals
• Distance information and treatment programs, using the Internet
• Relaxation training
• Problem solving training
High intensity = interventions of high complexity performed by the psychologist and/or in collaboration 
with the multidisciplinary team:
• Psychotherapy interventions: individual, group (stress management) or family (at least 1/week)
• Multidisciplinary interventions (evidence of the need to implement a structured psychotherapeutic intervention 
(cognitive-beavioral therapy, motivational, mindfulness, etc.)
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Coronary heart disease
A large body of empirical research shows that psychosocial risk fac-
tors, such as low socio-economic status, social isolation, stress, type-D
personality, depression and anxiety increase the risk of incident CHD
and also contribute to poorer health-related quality of life and prog-
nosis in patients with established CHD. Psychosocial risk factors may
also act as barriers to lifestyle changes and treatment adherence [4-6].
Based on epidemiological data, Rozanski recently divided the behav-
ioral risk factors for CHD into five broad categories:
a. Physical health behaviors, including physical inactivity, poor diet
and obesity, smoking, poor or inadequate sleep, inadequate rest
and relaxation
b. Negative emotions and mental mindsets including depressive
symptoms, anxiety, pessimism, anger and hostility
c. Chronic stress, including situational stressors (work stress, mar-
ital stress, social stressors, caregiver strain, childhood and adult
abuse, medical illness), and perceived stress
d. Social isolation and poor social support
e. Lack of sense of purpose.
Whilst psychosocial risk factors such as anxiety and depression can af-
fect the cardiovascular system through biological and behavioral pathways,
conversely CHD and its treatments can induce anxious and depressive re-
actions in the patient and caregiver. Depression disorder prevalence is be-
tween 15 and 20% in CHD and estimates of clinically-relevant depressive
symptoms are much higher [17,18]. A recent meta-analysis indicated a
16% rate of prevalence of anxiety disorders [19]. Recently, Pedersen et al.
[20] have provided a general overview of the prevalence of selected psy-
chosocial risk factors, their impact on patient-reported and clinical out-
comes, and biological and behavioral mechanisms that may explain the as-
sociation between psychosocial factors and health outcomes.
STRONG EVIDENCE
• Behavioral risk factors
 Physical inactivity, unhealthy diet, smoking [6]
 Sleep disorders [21,22]
 Inadequate rest and relaxation [4]
 Consumption of 3 or more alcohol beverages per day [6]. Data
are contrasting, however, regarding the moderate consump-
tion of alcohol: positive association [23]; negative association
[24,25]
 Use of cocaine (associated with increased cardiovascular risk,
e.g. tachycardia, arrhythmias, hypertension and vasospasm of
the coronary arteries) [26].
• Social factors
 Low socio-economic status, measured by educational and pro-
fessional level, income, and perceived working position 
[27-32]. In particular, individuals after acute myocardial in-
farction (AMI) with low income and low education are at risk
of premature mortality [33].
 Lack of social support [31,34]. Epidemiological studies have
shown that a reduced social network, poor social support
and/or its perception increase the risk of cardiac events [4].
The significant role of the various social factors has been con-
firmed by a recent meta-analysis of 148 studies [35]. Con-
versely, a good social integration was associated with an al-
most 2-fold increase in survival.
• Clinical depression and depressive symptoms
Both major depression and depressive symptoms increase the risk
of developing CHD and its worsening once the disease is manifest:
a review of 54 studies in fact documented an approximately 2-fold
increase in risk in both primary and secondary prevention [36].
Depression is especially deleterious to cardiovascular prognosis
post-AMI [17] and there does not appear to be a significant differ-
ence in prognosis between persons with pre-existing depression
and those developing depression post-AMI [37].
Also the syndrome known as “vital exhaustion” increases the risk
of new events [38,39].
• Anxiety and panic
In recent years the role of anxiety as a CHD risk factor has been
clarified. Several meta-analyzes have identified an increased risk
associated with anxiety symptoms both in population and in pa-
tient cohorts [40,41].
Recent studies have shown that the risk of CHD events is high
among patients with generalized anxiety disorder [42,43].
Among the anxiety disorders, evidence implicates generalised anxiety
disorder with poorer CHD prognosis in a recent metaanalysis [44).
• Stress
It is widely documented that acute stress (mourning, natural dis-
asters, terrorist attacks, football matches) can act as triggers of
acute coronary syndrome [45,46]. More complex is the analysis of
chronic stress related to specific situations:
 Psychosocial characteristics of work. The association be-
tween work stress and cardiovascular events has been further
documented over the course of time. Numerous studies [47-50]
have demonstrated that high demands combined with low
work control produce stress, and in a recent meta-analysis a
1.23-fold increase was reported in incidence of CHD in associ-
ation with job strain [48], compared with a 1.63-fold increase
in mortality associated with unemployment [51].
 Separation and divorce. Separation and divorce are another
common stressor that increase the risk of mortality; some epi-
demiological studies also suggest an association between mar-
ital tension and coronary events [4].
 Negative childhood experiences. Regarding negative child-
hood experiences, a large longitudinal study [52] showed that
women with severe childhood abuse had an approximately 
1.5-fold greater risk of early onset of cardiac events.
 Stress associated with disease. Diseases in themselves
constitute a stress factor, often leading to depression, anxiety,
social isolation and loss of self-esteem. In particular, the per-
ception of stress can also be an important determinant of
health [53,54].
• Post-traumatic stress disorder (PTSD)
Studies have reported the prevalence of post-AMI stress disorder
and PTSD to be as high as 30% [55], although a meta-analysis of
24 observational cross-sectional studies estimated the prevalence
to be 12% [56]. In any case, the rate of PTSD is much higher in car-
diac patients than in the general population (10-12% in men and 
5-6% in women) [57].
These patients may be prone to develop re-experiencing (e.g., re-
calling the cardiac event or defibrillator shocks, dreams of cardiac
arrest, flashbacks of the medical intervention and surgical proce-
dure), avoidance (e.g., avoiding reminders of the cardiac event
such as the location of the event, the hospital, medication, situa-
tions in which heart rate increases such as exercise or sexual ac-
tivity), and arousal symptoms (e.g., preoccupation with heart rate
or chest pain, insomnia) [58].
MODERATE EVIDENCE
• Personality factors
 Anger and hostility. Over the years it has been confirmed
that there is no association between type A personality and
pimeEDITRICE
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PSYCHOLOGICAL INTERVENTIONS
The position papers and psychological guidelines underline the need
for an effective management of these psychosocial risk factors, in-
cluding screening of psychosocial risk factors and implementation of
different psychological interventions programs such as counseling, mo-
tivational interviews, health psycho-education and psychotherapy.
Pogosova et al. [5] suggest the need for core competencies that
should include a screen for stress and psychosocial risk factors to iden-
tify clinically relevant levels of depression, anxiety, anger/hostility, re-
lationship stress and low social support. It may be more important to
teach patients how to change their existing stressors, or enhance their
coping mechanisms for existing stressors, rather than to change un-
healthy lifestyle habits. Therefore, it is essential to identify stressors
with the patients and support them in finding ways to attenuate these
stressors. This ideally should be carried out by trained personnel in
dedicated sessions dealing with stress [5].
Rozanski [4] suggests some evidence-based techniques developed
as management strategies for promoting healthy behaviors and the en-
hancement of psychosocial well-being, many of which are derived from
Cognitive Behavioral Therapy (CBT): health counseling, smoking ces-
sation, weight management, self monitoring, stress management, etc.
A large number of “multidisciplinary” studies have been conducted to
determine the effectiveness of psychosocial interventions for primary
and secondary prevention but often the effects of the psychosocial
components cannot be formally isolated from these studies.
The studies on psychological interventions for CHD patients have re-
ported positive effects on quality of life, health behavior, and somatic
risk profile, while others reported a protective effect on morbidity and
mortality [3]. Some studies showed small-to-moderate improvements
in depression and anxiety, a small reduction in cardiac mortality risk
[81] and a reduction in all-cause mortality risk for men, but not for
women [82]. Men appear to profit more from the interventions than
women, but less studies have been performed on women than men. In
particular, the meta-analysis by Whalley et al. [81] underlined the pos-
itive effects of psychological interventions on quality of life, depressive
symptoms and anxiety, as well as an effect on cardiac mortality. Linden
et al. [82] showed that programs which were initiated at least two
months after the cardiac event showed stronger effects on the rate of
future events than those initiated immediately after.
Welton et al. [83] carried out systematic literature searches to update
an earlier Cochrane review and classified components of interventions
into 6 types: usual care, educational, behavioral, cognitive, relaxation,
and support. Most interventions were a combination of these compo-
nents. There was some evidence that psychological interventions were
effective in reducing total cholesterol and standardized mean anxiety
scores, that interventions with behavioral components were effective in
reducing the odds ratio of all-cause mortality and nonfatal AMI, and that
interventions with behavioral and/or cognitive components were associ-
ated with reduced standardized mean depression scores.
coronary disease onset/outcome. A meta-analysis [59] con-
firmed that anger and hostility are associated with increased
risk of cardiovascular events both in the healthy population
and in coronary patients. However, the association is less than
that observed for depression and anxiety.
 Type D personality. A type D personality is present in about
one-third of patients with CHD [60] and predicts a poorer
prognosis [61-63], although some recent studies [64,65] have
shown contrasting results. Type D is also associated with wors-
ening of functional capacity and health status [66].
• Positive psychological variables
The role played by positive emotions (positive affect) in the devel-
opment of CHD is increasingly the subject of scientific research,
although it is still not completely clear [67]. Empirical evidence
suggests that there is an association between positive affective
states and health outcomes, including cardiovascular risk reduc-
tion and an increased resistance to infection [68]. Positive affec-
tivity according to Steptoe [68] may be part of a broader profile of
psycho-social resilience that reduces the risk of adverse outcomes
of physical health.
Positive psychosocial factors also promote physiological effects,
such as improvements in immune, endothelial, and autonomic
functions [69,70]. Optimism is associated with a higher experi-
ence of positive emotions, enhanced social functioning, and better
recovery from myocardial infarction and cardiac procedures. Re-
cent epidemiological studies have shown that pessimism increases
the risk for cardiac events, stroke and/or all-cause mortality,
whereas optimism exerts a buffering role [71-74].
MILD EVIDENCE
Some studies document different psychological profiles in relation to
gender and age, and there are growing data in the literature under-
lining the importance of psychosocial risk factors for the development
of CHD in women [75-80] (Table 2).
In summary, in the opinion of the Panel, from the literature analysis
there emerges:
– strong evidence of an association between the following variables
and onset/outcome of the disease:
• Behavioral risk factors
• Social factors
• Depression
• Anxiety and panic
• Stress
• Post-traumatic stress disorder
– moderate evidence of an association between the following vari-
ables and onset/outcome of the disease:
• Personality factors
• Positive psychological variables
pimeEDITRICE
Table 2. Evidence of association between the following variables and onset/outcome of CHD in women.
• depression [Ye S et al. 2012, Low et al. 2010, Shanmugasegaram S et al. 2012, Doeringet LV 2011, Möller- Leimkühler 2008]
• anxiety disorder [Doering 2011, Low et al. 2010]
• repressed anger [Low et al. 2010]
• low social support [Möller-Leimkühler 2008]
• stress associated with family relationships or responsibility [Low et al. 2010, Georgiades A 2009]
In women, general anxiety, hostility and work-related stress are less frequently associated with CHD [Low et al. 2010]
Women report more stressful life events and other psychosocial risk factors in the year following discharge [Georgiades 2009]
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Pogosova et al. [5] affirmed that stress management should be of-
fered to patients (on an individual basis or in small groups) and that
significant others should be included in the programs.
In a systematic review, Dickens et al. [84] sought to identify the
characteristics of psychological interventions that improve depression
and depressive symptoms among people with CHD. The results show
that psychological interventions improved depression, although the ef-
fect was small. Problem solving, general education, skills training,
CBT and relaxation had small effects on CHD patients, who were re-
cruited irrespective of their depression status. Among high-quality
trials of depressed CHD patients, only CBT showed significant, though
small, effects. The systematic review of Van Dixoorn [85] on the ef-
fectiveness of relaxation therapy showed positive effects on cardio-
logic variables, anxiety and depression, and work reintegration A re-
cent review of psychotherapy interventions for patients with ischemic
heart disease [86] showed positive effects on conditions of psycho-
logical distress, on the management of traditional risk factors and
with respect to some cardiovascular prognostic indices. Data from the
literature on the effectiveness of the above-mentioned psychological
interventions and evidence-based psychotherapy are mainly based on
CBT interventions; however, one can also find evidence of efficacy of
interventions based on other theoretical models, though these require
further confirmatory studies. Most of the studies with CBT involve in-
dividual and/or group interventions carried out in the context of re-
search, mainly in outpatient settings - the average duration is about
one year with weekly sessions in the early stages followed by monthly
sessions in the second part.
Table 3 reports the major studies on CBT interventions carried out in
CHD patients [87-105].
In the literature there are few reports of psychotherapeutic inter-
ventions with a non-cognitive-behavioral orientation. A randomized
clinical trial conducted in 2013 by Roncella et al. [106] shows the effi-
cacy of a psychoanalysis intervention (group and individual) on cardiac
symptoms, quality of life, and psychological/medical outcomes at 1-year
follow-up. Lesperance [107] shows the effectiveness of interpersonal
psychotherapy on reducing depression in a sample of patients with
CHD. However, further studies are required due to the low number of
studies and short follow-up duration (1 year).
The updated Cochrane Review [7] found that for people with CHD
there was no evidence that psychological treatments had an effect on
total mortality, risk of revascularisation procedures, or on the rate of
non-fatal AMI, although the rate of cardiac mortality was reduced and
there was a reduction in psychological symptoms (depression, anxiety,
or stress); however, the GRADE assessments suggest considerable un-
certainty surrounding these effects. There is also considerable uncer-
tainty about who would benefit most from treatment (i.e., people with
or without psychological disorders at baseline) and what the specific
components of successful interventions are. For depression, psycholog-
ical interventions combined with adjunct pharmacology (where
deemed appropriate) for an underlying psychological disorder appeared
to be more effective than interventions alone without adjunct pharma-
cology. For anxiety, interventions recruiting participants with an un-
derlying psychological disorder appeared more effective than those de-
livered to unselected populations.
In the Panel’s opinion, from the literature analysis, it can be stated
that there is:
– existence of strong evidence for the efficacy of cognitive-behav-
ioral interventions on the following variables:
• depression
• anxiety
• stress
– existence of moderate evidence for the efficacy of cognitive-
behavioral interventions on cardiac outcomes
– existence of mild evidence for the efficacy:
• of interpersonal psychotherapy on depression
• of short-term psychoanalytic therapy on quality of life and car-
diac outcomes
• of mindfulness interventions on anxiety, depression, stress,
cardiac outcomes
Cardiac surgery
Takagi et al. [108] performed a systematic review and meta-analysis
to determine whether perioperative depression and anxiety were asso-
ciated with increased postoperative mortality in patients undergoing
cardiac surgery. Neurocognitive and psychiatric complications are
common following cardiac surgery and impact on the patient’s quality
of life, recovery, participation in rehabilitation and long-term mortality.
Postoperative cognitive decline, depressive disorders, post-traumatic
stress disorder and neurocognitive impairment related to silent brain
infarcts have all been linked to the perioperative period of cardiac sur-
gery, and can have potentially serious consequences. The accurate as-
sessment of these conditions, particularly in determining the etiology,
and impact on patients is difficult due to the poorly recognised nature
of these complications as well as similarities in presentation to post-
operative delirium [109].
MODERATE EVIDENCE
• Anxiety and depression
The literature search by Takagi et al. [108] included data on
236,595 patients undergoing cardiac surgery - coronary artery
by-pass grafting (CABG), CABG with concomitant valve replace-
ment, valve surgery - and showed that perioperative depression
and anxiety may be associated with increased postoperative
mortality. Depression and/or anxiety before an invasive inter-
vention may negatively influence coping and recovery after the
intervention.
• Post-traumatic stress disorder (PTSD)
In a narrative review, Singh [110] affirmed that PTSD has a strong
association with CABG and can be a source of considerable mor-
bidity and mortality, although the studies on which these state-
ments are based are not recent. In primis, the study of Stoll et al.
[111] compared patients undergoing cardiac surgery with healthy
persons and those undergoing other types of surgery and noted a
higher incidence of PTSD in cardiac surgery patients. The authors
observed that patients after CABG with comorbid PTSD had a lower
compliance with respect to use of medication, which carries the
risk of an unfavorable course of the somatic disease. Also, the risk
for rehospitalization after AMI is higher in patients with comorbid
PTSD symptoms than in patients without.
• Post-surgery neuropsychological disorders
A systematic review of 2014 [112] stated that persistent cognitive
impairment attributable to cardiovascular surgery in patients aged
over 65 years is infrequent, and may reflect pre-existing cognitive
impairment. In particular, CABG interventions seem to have
modest effects in the medium and long term. Results cannot be
generalized to the oldest-old, to women or to patients with pre-ex-
isting cognitive impairments. Postoperative decline appears to be
associated with the presence of new ischemic lesions from emboli
during surgery, but the pathogenesis seems still unclear and also
hard to predict [113].
pimeEDITRICE
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ENRICHD
(Berkman et al.,
2003)
Blumenthal et al.,
2005
Claesson et al.
(2005)
McLaughlin et al.
(2005)
Michalsen et al.
(2005)
Sebregts et al.
(2005)
Edelman et al.
(2006)
RCT
RCT
RCT
RCT
RCT
RCT
RCT
Multi-center
Single-center
Single-center
Single-center
Single-center
Single-center
Single-center
2481 (1397 males
and 1084 females;
1238 intervention
and 1243
controls)
134 patients 
(92 males and 
42 females; 44
intervention and
42 controls 1 and
48 controls 2)
198 (only
females; 
101 intervention
and controls)
100 (74 males
and 26 females;
53 intervention
and 47 controls)
101 (78 males
and 23 females;
48 intervention
and 53 controls)
204 (169 males
and 35 females;
106 intervention
and 98 controls)
154 (30 males
and 124 females;
77 intervention
and 77 controls)
AMI
Patients with
stable ischemic
heart disease (IHD)
and exercise-
induced myocardial
ischemia
Ischemic heart
disease
ACS
Stable or
unstable CAD
AMI or CABG
Patients with 
1 or more known
cardiovascular
risk factors
61
63
61
60
59
55
53
29 months
1
10
Group and individual
cognitive-behavioral
therapy, education,
relaxation, and type A
behavior modification
for 18 contact hours.
Weekly 1.5-hour
stress management
training for 16 weeks.
Cognitive-behavioral
stress management
program vs usual
care 1-year.
CBT, counselling,
education for 8-week
treatment sessions
were 30 minutes 
and conducted 
by doctoral-level
clinicians with
telephone.
CBT, relaxation, 
and type A behavior
modification 
for 96 contact hours.
A combined stress
management 
and health education
program during eight
weekly 2.5-h
sessions.
Personalized health
planning (PHP): 
usual care associated
with educational
couselling and
mindfulness
meditation,
relaxation training,
stress management,
motivational
techniques, and
health education 
and coaching.
Improvements in depression 
and social support. There was 
no benefit in terms of cardiac
outcomes or mortality after
follow-up.
Less emotional distress 
and lower levels of depression
compared with usual care
controls. Improved markers 
of cardiovascular risk more than
usual medical care alone.
Both groups improved in all
psychosocial variables the rate 
of improvement was significantly
greater in the intervention group
for self-rated stress behavior
(P=0.006) and vital exhaustion
(P=0.03).
27% improvement in depression
symptoms (P=0.05), 27% in
anxiety (P=0.02), and a 38%
improvement in home limitations
(P=0.04).
Both groups improved in QoL,
and significantly greater
improvements for the lifestyle
group were found for physical
function and physical sum score
(P=0.046 and P=0.045). Depression,
anxiety, anger and perceived stress
were reduced similarly in both
groups. Greater benefits among
women in the lifestyle intervention
vs advice group for depression
and anger (P=0.025 and P=0.040),
but no effects for men.
Reduction of hostility and total
Type A behavior at post
intervention (P=0.01) and at 
9-month. Follow-up (P=0.03).
The intervention had no overall
impact on vital exhaustion and
depression, whereas we
unexpectedly found that the
percentage of patients with
major depression was reduced 
in the control group but not 
in the intervention group.
Baseline 10-year risk of CHD was
11.1% for subjects randomized 
to Usual Care (n=77), and 9.3%
for subjects randomized to PHP
(n=77). Over 10 months of the
intervention, CHD risk decreased
to 9.8% for UC subjects and 7.8%
for intervention subjects. 
A multidimensional intervention
based on integrative medicine
principles reduced risk of CHD,
possibly by increasing exercise
and improving weight loss.
Table 3. Major studies on CBT interventions in CHD patients.
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Koertge et al.
(2008)
Albus et al.
(2009)
Blom et al.
(2009)
Griffiths et al.
(2009)
Neves et al.
(2009)
Orth-Gomér et al.
(SWITCHD,
2009)
RCT
RCT
RCT
Pilot study
RCT
RCT
Single-center
Single-center
Single-center
Single-center
Single-center
Multi-center
247 (only females; 
119 intervention
and 128 controls)
77 (67 males 
and 10 females;
39 intervention
and 38 controls)
247 (only females;
13 intervention
and 122 controls)
6 (5 males 
and 1 female)
81 (69 males 
and 11 females;
41 intervention
and 40 controls)
237 (only females;
112 intervention
and 125 controls)
AMI, PCI or CABG
Patients with
stable CHD
CAD
Diagnosed
cardiac 
condition that
required cardiac
rehabilitation
Stable 
or unstable CAD
AMI, PCI 
or CABG
62
54.2 +/- 6.9
years
≥75
50
60
62
After 1, 2, 3,
and 7 years
After 1 
and 2 years
2
7
Group cognitive-
behavioral therapy,
education, relaxation,
and type A behavior
modification for 40
contact hours.
Multimodal, behavioral
intervention and
relaxation training 
10 sessions once a
week followed by 9
subsequent sessions
once a month, which
included group
discussions,
relaxation and
exercise training,
which continued for a
period of up to 1 year.
20 (2-h group
sessions) of stress
management therapy.
Mindfulness based
Cognitive Therapy
eight-week (two
hours per week).
Mindfulness-based
Cognitive Therapy
group developed by
Segal, Williams and
Teasdale (2002)
adapted for a cardiac
population.
Group relaxation
therapy for 3 months
vs usual care.
20 Group cognitive-
behavioral therapy for
12 months. Educational
group sessions were
aimed at improving
knowledge of the
heart, healthier
lifestyle, training
skills, and improving
mastery of marital
stress, coping with
serious illness,
counteracting anxiety
and depression,
improving social
relations and social
support, and
practicing relaxation
techniques.
For VITAL exhaustion, intention
to treat analysis showed effects
for time (P<0.001) and time x
treatment interaction (P=0.005),
reflecting that both groups
improved over time, and that 
the decrease of VE was more
pronounced in the intervention
group.
Improvement of miocardial
perfusion.
Reduction of self-rated daily
stress behavior over time 
compared to controls.
Development of awareness,
commitment, within group
experiences, relating to the
material and acceptance as
central experiential themes.
Absence of a control group 
and small sample size number 
is in accordance with IPA sample
sizes. Interpretive
phenomenological analysis (IPA)
of participant experiences.
Perceived stress declined more
in the intervention group and 
it had significantly lower heart
rate, blood pressure, and rate-
pressure product values after
the program (P <or= .0001).
Relaxation therapy was
associated with a positive effect
on psychological stress 
and hemodynamic variables.
No difference in the follow-up.
Women in usual care 
had a mortality rate of 20%, 
whereas those in the
psychosocial intervention 
had a mortality rate of 7%. 
No women were lost 
to follow-up.
Table 3. Continued from previous page.
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Blumenthal et al.
(2010)
ENHANCED
Gulliksson et al.
(SUPRIM, 2011)
Goodwin et al.
(2012)
Orth Gomer et al.
(2012)
Murphy et al.
(2013)
Parswani et al.
(2013)
RCT
RCT
Pilot study
Observational
study
RCT
RCT
Multi-center
Single-center
Single-center
Single-center
Multi-center
Single-center
150
362 (277 males
and 85 females;
192 intervention
and 170 controls)
16 (5 males 
and 11 females;
all intervention)
30 (19 males 
and 11 females;
all intervention)
275 (238 males
and 37 females;
139 intervention
and 136
controls)
30 (only males;
15 intervention
and 15 controls) 
CHD
Stable or
unstable CAD
Acute coronary
syndrome
Acute coronary
syndrome
AMI, PTCI 
or CABG
AMI, PTCI 
or CABG
CHD
≥35
62
56.4
55.5
59
48.5
7.8
9
2
3 months
Stress management
training (SMT) 
vs traditional
exercise based
cardiac rehabilitation 
for 12 weeks.
CBT 40 contact hours
spanning 1 year 20
two-hour sessions 
of group-based
stress management. 
The groups consisted 
of 5 to 9 same-sex
participants, 5 key
elements (education,
self-monitoring, skills
training, cognitive
restructuring, and
spiritual development)
and was focused 
on stress reduction 
and management.
ACT four, 90-min
group sessions
focused on developing
mindfulness and
distress tolerance
skills, and
strengthening
commitment to
health-related
behavior change.
CBT: ten sessions 
of two hours of
stress management
program.
“Beating Heart
Problems” cognitive-
behavioral therapy
and motivational
interviewing program
vs usual care.
Mindfulness-Based
Stress Reduction
(MBSR) program.
Cardiac rehabilitation enhanced
by SMT produced significant
reductions in stress and greater
improvements in medical
outcomes compared with
standard CR. Our findings
indicate that SMT may provide
incremental benefit when
combined with comprehensive CR.
Group undergoing CBT had 
a lower rate of fatal and non-fatal
first recurrent cardiac events;
fewer recurrent acute
myocardial infarctions and a non
significant lowering of all-cause
mortality. In patients with CVD 
an intensive 40-hour group-based
CBT program decreased the risk
of recurrent CVD and AMI.
Satisfaction with the
intervention. Large
improvements in diet 
and moderate increases 
in physical activity from 
pre- to post-treatment.
No gender differences but
discussion styles varied between
the women and men, Women were
more open and more personal.
Family issues were more frequent
than job issues, although all
women were employed outside
their homes. Men talked about
concrete and practical things,
mostly about their jobs, and not
directly about their feelings.
Daily stresses of life decreased
significantly for both men and
women, but more so for women.
Depressive thoughts were low at
baseline, and there was no change
over time. In contrast, anxiety
scores were high at baseline and
decreased significantly, but more
so for women than for men.
Compared with the C group patients,
intervention group patients tended
toward greater reduction in 2-year
risk of cardiac event, at both the 4- and
12-month follow-up. Significant benefits
in dietary fat intake and functional
capacity were also evident.
Significant reduction in symptoms
of anxiety and depression,
perceived stress, blood pressure
and body mass index in patients 
of the MBSR group after the
completion of intervention
assessment. At 3-month follow-up,
therapeutic gains were maintained
in patients of the MBSR group.
Table 3. Continued from previous page.
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In a long-term study with a median follow-up of 11 years in patients
following cardiac surgery, cognitive dysfunction present at 6 months
was associated with increased long-term mortality [114], further
demonstrating that the consequences of postoperative cognitive dis-
function are likely to have long-term implications that are more sig-
nificant than simply that of a ‘transient postoperative state’. Cogni-
tive functions were reported to be mildly or not significantly impaired
after transcatheter aortic valve implantation (TAVI) [115]. Postoper-
ative delirium is associated with increased anxiety and depression at
6 to 9 months, and future investigation should seek to evaluate the
utility of screening programs for affective disorders in those individ-
uals who develop delirium in the postoperative period [116].
In summary, in the opinion of the Panel, from the literature analysis
there emerges:
– moderate evidence of an association between the following vari-
ables and clinical condition
• Anxiety and depression
• Post-traumatic stress disorder
• Post-interventions neuropsychological disorders
PSYCHOLOGICAL INTERVENTIONS
A literature concerning specific psychological interventions can not
be found.
Suarez-Bagnasco [117] suggests that the study of psychological is-
sues in these cardiac diseases is relevant and could provide informa-
tion about specific needs requiring psychological interventions as well
as be useful for the design of specialized care training and practice.
A good practice intervention is recommended.
Chronic heart failure
The European guidelines [118] underline that CHF is a common
chronic disease with poor prognosis and significant quality of life limita-
tions. Patients are required to follow a complex regimen of self-care be-
haviors including medication, self-monitoring of symptoms, diet and ex-
ercise. Mental comorbidities such as depressive and anxiety disorders
are common in patients with CHF. Depressive comorbidities are present
in about 20% of patients, anxiety comorbidities in up to 40% [119].
STRONG EVIDENCE
• Behavioral risk factors
Obesity, sedentary lifestyle, smoking, and cocaine and alcohol use
are independent predictors of CHF [118,120-122]. Goel et al., how-
ever, show that light to moderate alcohol intake has been associ-
ated with lower risk of heart failure [25].
• Depression
A systematic review and meta-analysis suggests that depression is
an important and independent predictor of all-cause mortality
among CHF patients, while anxiety does not appear to have a
strong effect [100].
• Anxiety
The above-mentioned systematic review and meta-analysis [100]
showed that anxiety does not appear to have as strong an effect as
depression in predicting all-cause mortality among CHF patients,
but anxiety is negatively associated with self-care behavior. How-
ever, this effect disappears behind the stronger influence of de-
pression on self-care. It is important to consider mental comor-
bidities in patients with CHF [123].
MODERATE EVIDENCE
• Social factors
Low socio-economic status (SES) as well as immigrant status are
independent predictors of CHF [124,125]. Social instability and
poor social support, instability and precariousness of affective/in-
terpersonal relationships, not being married, living alone, some so-
cial and environmental factors such as immigrant status, distance
from the hospital and precarious housing conditions negatively af-
fect the outcome [124-127].
• Personality factors
Type D personality. Data in the literature are contradictory and
inconclusive [61,128-132].
• Positive psychological variables
Positive psychological well-being improves the outcome in terms of
quality of life and disease management [133,134].
• Neuropsychological disorders
Mild cognitive impairment (MCI) is common in HF and impacts on
patients’ engagement in self-care, yet it is frequently not de-
tected.[135].
• Sleep disorders
Sleep disorders and apnea influence the outcome [136,137].
In summary, in the opinion of the Panel, from the literature analysis
there emerges:
– strong evidence of an association between the following variables
and disease onset/outcome:
• Behavioral risk factors, in particular alcohol and cocaine use
• Depression
• Anxiety
– moderate evidence of an association between the following
variables and disease onset/outcome:
• social factors
• personality factors (type D)
– moderate evidence of an association between the following vari-
ables and outcome of the disease:
• positive psychological variables
• neuropsychological disorders
• sleep disorders
PSYCHOLOGICAL INTERVENTIONS
The analysis of the literature [138-141] shows that it is fundamental
to treat patients with CHF from the perspective of a chronic and pro-
gressive disease, during which they are called upon to put into action
cognitive, emotional and behavioral resources that will allow them to
live with the disease, adhere to complex therapeutic regimens and
maintain a reasonable level of quality of life. The changes of role in the
personal, family, and social/work context involve problematic emotional
states; moreover, adherence to prescriptions is often conditioned by the
complex pharmacological therapy, by the need to monitor physiological
parameters and symptoms, and by food restrictions (salt consumption,
intake of liquids, abstention from alcohol).
From the literature and from clinical experience it emerges that in-
terventions to optimize the CHF treatment, reduce hospitalizations and
mortality, and improve quality of life and management of the disease,
carried out during the stay in hospital or at home with telemedicine
methods or face-to-face interventions, are linked to two key aspects: 
i) self-management and adherence [142-147]; ii) depression and anx-
iety [148-150].
Self-management should be promoted right from the outset, main-
tained throughout the course of the illness, and sustained in the
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logical aspects of telerehabilitation [175]. These patients could receive
parallel psychological support and tele-assistance from the telemoni-
toring team (nurse, physician, physiotherapist). In any case, telemedi-
cine interventions can provide benefits to heart failure patients only as
part of a shared and integrated multidisciplinary and multi-profes-
sional ‘chronic care model’ [176].
In this context, one can envisage:
– interventions aimed at self-management based on brief psycholog-
ical techniques (such as motivational interviews and CBT) per-
formed by healthcare operators, especially nurses, trained by psy-
chologists
– psychological/psychotherapeutic interventions carried out by psy-
chologists/psychotherapists, of a prevelently cognitive-behavioral
type
– telemedicine interventions, performed by healthcare operators, es-
pecially nurses, which should be trained by psychologists
In the Panel’s opinion, from this analysis of the literature there
emerges moderate evidence of efficacy
• for cognitive-behavioral interventions
• for psychoeducational and disease management interventions.
Heart transplantation
The specific Guidelines [177,178] affirm that the psychologist
should routinely assess all patients being considered for heart trans-
plantation (HT), before wait-listing for transplantation. Evaluation
should include an assessment of the patient’s ability to give informed
consent and comply with instructions, including drug therapy, as well
as assessment of the support systems in place at home or in the com-
munity. This assessment focuses on the following: i) social support and
the ability of the social support network to cope with the stressors of HT
care; ii) patient understanding of the requirements, risks and benefits
of HT; iii) adherence to the medical care plan; iv) psychopathology; 
v) cognitive assessment. The literature on psychological comorbidity
[177,179,180] shows a high incidence of anxiety-depressive disorders
(30%) pre-transplantation, which tends to decrease in post-transplan-
tation. Psychological/psychiatric contraindications are first reviewed by
the psychologist and, where necessary, a psychiatrist is consulted for
further assessment and/or a second opinion.
STRONG EVIDENCE
• Behavioral risk factors
The presence of substance-related disorders, personality disorders or
a history of medication non adherence are powerful predictors of
failure to comply with the medical regimen and, therefore, are associ-
ated with increased morbidity and mortality in HT patients [180-182].
• Depression
Major depression pre-transplant is a negative prognostic factor es-
pecially if associated with poor social support [183,184]. It ad-
versely affects adherence to exercise and participation in daily life
activities [185].
Its incidence was 7.9% for severe or moderate depression [186]
and 33-69% for the less severe levels [187,188]. If the depressive
symptomatology is treated pharmacologically, symptoms can be re-
duced and the health status improved post-transplant [189]. A re-
cent systematic review indicated that depression increases the risk
of post-transplant mortality [190]. The presence of depression
post-transplantation is frequent [191], equal to 41%. Grandi et al.
[192] reported that demoralization in combination with depres-
phases of instability, in the transition from hospital to home and in the
terminal phases [139,145,151-153]. Interventions to improve self-man-
agement do not affect the emotional structure [153]. In a recent review
[154] on the effectiveness of psychological interventions on self-care,
and on psychological and health outcomes in patients with CHF, the au-
thors showed that nurses play an important role in patient education
and secondary prevention. Compared to other professionals, nurses
have more patient contact opportunities and are more holistic in all as-
pects of disease management; therefore, more nurses can be trained to
incorporate the brief psychological techniques (such as motivational
interviews and CBT) to maximize the intervention’s effectiveness. The
main limitation of the review is the moderate-to-high level of hetero-
geneity among the included studies, which could partially undermine
the reliability and reproducibility of the results. Due to the hetero-
geneity of the studies, no definitive conclusions on the optimal format
and forms of intervention could be drawn. Replication of the studies is
required in the future to isolate the active component of the interven-
tions and identify the ideal format and dosage of interventions.
An improvement of adherence is achieved through effective commu-
nication and by defining with the patient an interactive therapeutic
plan aimed at the respect, recognition, correction and management of
these aspects:
• Psychosocial: psychological problems, neuropsychological deficits
and poor socio-family support [155,156].
• Cognitive behavioral: cognitive distortions about awareness, self-
management of the disease at home and self-efficacy [156-158].
• Communications: [159, 146].
In published reports, details on specific counseling or psychothera-
peutic interventions (cognitive therapy and stress management) for
patients with CHF are often lumped together as part of the group of
non-pharmacological approaches (including physical activity and di-
etary prescriptions) or are included in the global rehabilitation treat-
ment or as part of the multidisciplinary hospital interventions 
[160-167], so it is difficult to document their specific effectiveness.
Psychological interventions can be performed to address dysfunc-
tional aspects (cognitive, emotional or behavioral) in the management
of the disease, or to provide counseling to optimize coping strategies,
or to provide psychological support during the stabilization phase
[168].
Many reports focus on depression and the provision of emotional
support or counseling in order to understand the patient’s needs,
manage their emotional response to the disease, improve quality of life
and optimize the physical outcomes of the therapeutic interventions.
In a recent systematic review and meta-analysis [169], a CBT inter-
vention on depression, quality of life, hospitalizations and mortality
in CHF patients was associated with a greater improvement, compared
to usual care, in depression scores both at the end of the CBT program
and 3 months later. Greater improvement in quality of life scores was
evident for the CBT group initially after CBT sessions, but there was no
difference at 3 months. Hospital admissions and mortality were similar
in the two treatment groups. CBT may be more effective than usual
care at improving depression scores and quality of life for heart
failure patients initially following CBT and for depression at 3 months.
The authors suggest larger and more robust randomized controlled
trials (RCTs) to evaluate the long-term clinical effects.
There are also specific interventions based on specific theoretical
health models [170] or therapies associated with positive psychology
[171] and with the most recent CBT therapy [172-174].
Telerehabilitation may serve as a helpful strategy for continuing at a
distance the monitoring and management of a patient, allowing face-
to-face interventions, including with the patient’s family. To date, only
a small number of studies have been dedicated to studying the psycho-
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sion predicted more acute rejection episodes in the 6-year period
post-transplant than either variable considered independently.
Major depression prior to heart transplantation is a risk factor for
post-transplant malignancies and PTSD symptoms are a predictor
of post-transplant poor adherence [191].
MODERATE EVIDENCE
• Social factors
The presence of poor social support post-transplantation is corre-
lated to a worse quality of life [193] as is low socio-economic status,
living in an urban reality [182] and having a caregiver with anxious-
depressive symptoms [194,195]. Conversely, high education level
and a medium-high economic status are predictive of greater sur-
vival [182,196,197]. Any patient for whom social supports are judged
to be insufficient to ensure care compliance in the outpatient setting
may be regarded as having a relative contraindication to HT [178].
• Anxiety
In the recent systematic review cited above, anxiety was not asso-
ciated with e risk of post-transplant mortality and morbidity [190].
However, anxiety appears to be present in the pre-transplant
waiting-list phase [179,180,198]. Anxiety negatively affects the
psychophysical health status [199].
• Stress
HT is a very stressful experience for heart transplant candidates,
and recipients and patients have to cope with significant medical
and emotional challenges related to the workup they must undergo
for listing, waiting for a donor heart to become available, under-
going surgery and post-operative recovery, and adjustment to life
with a transplanted organ [180].
At 5 and 10 years after HT, the most bothersome stressors regard
work, school, and financial issues. Patients at 10 years after trans-
plant reported less stress, similar stress intensity, and less use and
perceived effectiveness of negative coping than patients at 5 years
after transplant. In the long-term after transplant, demographic
characteristics, psychologic problems, negative coping, and clinical
factors were related to stress frequency and/or intensity [200]. 
HT-related stress occurs in the long-term after surgery. Types of trans-
plant-related stress and factors related to stress confirm the impor-
tance of ongoing psychologic and clinical support after HT [200].
• Post-traumatic stress disorder
Its incidence in transplanted patients is 12%. In a study [191], the
estimated frequency of psychiatric diagnoses after HT was 12% for
transplantation-related PTSD and 41% for major depression. The
presence of an episode of major depression prior to HT is a signif-
icant independent risk factor for post-transplant malignancies.
Age, post-transplant malignancies and poor adherence are signifi-
cant predictors of mortality in the survival analyses. Mortality was
significantly higher in patients with HT-related PTSD comorbidity,
possibly as a result of the lower compliance in these patients or the
fact that PTSD itself is predictive for poor health status.
• Personality factors
Neuroticism [179,180] is correlated to anxiety and depression,
thus constituting a predictive factor of psychopathology 12 months
after HT. High levels of hostility are an independent predictor of
subsequent mortality. Part of post-transplant nonadherence seems
also to be determined by personality. Personality traits refer to a di-
mensional taxonomy created to understand normal personality
functioning, and do not necessarily reflect psychopathology. Pa-
tients with low conscientiousness may be criticized for their care-
lessness, negligence, and failure to stay within the lines, while pa-
tients with high conscientiousness are disciplined, organized,
goal-oriented, and have a high need for structure, i.e. all charac-
teristics that may help people in treatment adherence [181].
• Personality factors
Type D is a predictor of morbidity and mortality [201,202].
• Disease management
Different studies have found that HT candidates use positive coping
strategies more frequently than maladaptative coping strategies
such as denial, avoidance or disengagement [197,203]. Consistent
with the results obtained by the group of Burker [197,203], mal-
adaptive coping styles (including disengagement dimension and
some help-seeking traits such as venting of emotions or seeking
emotional support) were associated with the presence of psychiatric
symptoms in a group of patients [179], also after a follow-up of 12
months [180]. Adherence was poor post-transplantation [204,205].
Prognostically favorable factors for adherence were high education
level and having a female caregiver or being a female [205].
• Positive psychological variables
The state of psychophysical wellbeing, optimism and the percep-
tion of exercising active control over the disease are prognostically
favorable indicators for the outcome [206,207].
• Neuropsychological disorders
They have an incidence in the pre-transplant phase that ranges
from 15 to 59% [187], while other studies show an incidence equal
to 86% in particular in the executive functions [208]. There are no
indications for excluding from the list for HT patients with mental
retardation and specific cognitive deficits [187,208,209]. A sub-
stantial proportion of long-term survivors of HT might be cognitively
impaired. The level of impairment appears comparable to what is
defined in the literature as mild cognitive impairment [210]. The
benefit of HT in patients with severe cognitive-behavioral disabili-
ties or dementia (e.g. self-injurious behavior, inability to under-
stand and cooperate with medical care) has not been established;
on the contrary, it has the potential for harm and, therefore, HT
cannot be recommended for this subgroup of patients [178].
In summary, in the opinion of the Panel, from the literature analysis
there emerges:
– strong evidence of an association between the following variables
and the conditions of pre- and post-transplant:
• Behavioral risk factors
• Depression
– moderate evidence of an association between the following vari-
ables and the conditions of pre- and post-transplant:
• Social factors
• Anxiety
• Stress
• Post-traumatic stress disorder
• Personality factors
• Disease management
• Positive psychological variables
• Neuropsychological disorders
PSYCHOLOGICAL INTERVENTIONS
Psychotherapeutic interventions
A recent systematic review recommends, as good practice, psy-
chotherapeutic interventions of a cognitive-behavioral type, stress
management strategies and relaxation techniques as a means to re-
duce the state of psychological distress and promote improved quality
of life. In post-transplantation, also psycho-social support interventions
carried out telematically via the Internet have shown to be effective
[211]. The use of mindfulness training (mindfulness-based stress re-
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• Depression
• Anxiety
• Acute and chronic stress
• Psycho-physiological sleep disorders
• Cognitive deficits
PSYCHOLOGICAL INTERVENTIONS
To date, there are no RCTs on large populations able to demonstrate
the efficacy of a specific psychological intervention on patients with
LVAD. There are indications that patients who undergo, post-LVAD im-
plantation, a course of treatment including psycho-education, re-edu-
cation in physical activity and self-care, as well as psychological support
to the patient and caregiver, show greater functional improvement in
depression [234-239], in maintenance of a correct diet and in mainte-
nance of adequate physical activity [240].
In the opinion of the Panel, from the analysis of the literature there
emerges:
– mild evidence for the efficacy of cognitive-behavioral interventions
in reducing the state of psychological distress
– mild evidence for the efficacy of psychoeducational and manage-
ment interventions
Implantable cardioverter-defibrillator (ICD)
The acceptance of the ICD appears to be influenced by a number of
variables such as psychological morbidity, advanced age, severity of the
disease, onset of anxious or depressive symptoms, type D personality,
worry about the ICD implantation, and understanding of the benefits
and disadvantages of the ICD, which would seem to impact on the per-
ceived quality of life [241-244].
MODERATE EVIDENCE
• Depression
The frequency and severity of depressive symptoms would appear
to increase in relation to the severity of the underlying CHF
[245,246].
• Anxiety and fear
Catastrophic thoughts underlying the manifestation of anxiety pro-
voke in the patient the avoidance of daily, physical and sexual ac-
tivities [242,247] or the presence of anticipatory anxiety in rela-
tion to random stimuli such as, for example, increased heart rate
during moderate physical activity [248]. In particular, higher levels
of anxiety emerged in young patients [249] and in women espe-
cially as regards body image [250,251]. The results of the PainFree
SST Clinical Trial [252] showed that ICD shocks have a long-
lasting, adverse impact on both objective, device-measured phys-
ical activity and subjective patient-reported outcomes of quality of
life and shock anxiety. Shock anxiety increased in shocked patients
and remained significantly elevated at 24 months, regardless of
whether the shock delivery was appropriate or inappropriate. Suc-
cessful management of ICD patients requires attention to clinically
relevant behavioral and psychological outcomes to speed their re-
covery and return to activities of daily living.
• Post-traumatic stress disorder
In a narrative review, Sears [253] found that patients under the
age of 50 years, female, with psychiatric pre-morbidity, poor social
support and less than 5 discharges (appropriate or inappropriate)
were at higher risk of PTSD. Furthermore, the presence of PTSD
duction, MSBR) lasting 8 weeks was effective in reducing symptoms of
anxiety, depressive symptoms and sleep disorders post-transplant
[212]. Observational studies recommend the practice of individual psy-
chotherapeutic interventions aimed not only at the patient but also at
the caregiver and the healthcare team [213].
Management interventions
The patient’s adherence to treatment, psychophysical wellbeing and
quality of life are better if the healthcare team has developed adequate
interpersonal relationship skills and uses strategies of motivational
counseling [214]. Management models that include educational inter-
ventions, periodic monitoring and telematic support extended to care-
givers in the months following the transplant event are predictive of good
adherence to treatment [215,216]. It is also recommended to provide in-
terventions for the prevention of relapse in smoker patients [217].
In summary, in the opinion of the Panel, from the literature analysis
there emerges:
– Strong evidence for the efficacy of cognitive-behavioral interven-
tions in reducing the state of psychological distress
– Moderate evidence for the efficacy of psychoeducational and man-
agement interventions
Mechanical ventricular assist devices
Currently there are not many studies that have investigated the
psychological aspects, and the number of patients examined is very
modest. Two systematic reviews investigated the impact of left ven-
tricular assist device (LVAD) implantation on psychological vari-
ables [218,219], and showed an improvement in the state of psycho-
physical health, depression and anxiety scores in patients after
LVAD implantation. Factors contributing to changes in depression
and anxiety after the LVAD implant could be related to the improve-
ment in acute heart failure symptoms, functional capacity, and
quality of life [220].
MODERATE EVIDENCE
• Acute and chronic stress
The immediate post-operative period is associated with an in-
crease in negative emotions (fear of the outcome of the interven-
tions and of hospitalization) [221].
• Depression
Depression is particularly present in the post-implantation period
[222-226].
• Anxiety
Anxiety is frequent in patients with LVAD [222-226].
• Psycho-physiological sleep disorders
After LVAD implantation there are problems in the area of sleep
that correlate with the presence of anxiety and depression
[219,227,228].
• Neuropsychological disorders
In patients with LVAD implantation, cognitive dysfunctions may be
present, but they are mainly found in older patients and in those
with LVAD as destination therapy [229]. In general, the LVAD im-
plant seems to arrest the cognitive decline [230] and, in the space
of 24 months, there is an improvement in cognitive functions with
respect to patients with advanced heart failure [231-233].
In summary, in the opinion of the Panel, from the literature analysis
there emerges moderate evidence for an association between im-
planted LVAD and the following variables:
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appears to be associated with a greater percentage of shock expe-
riences and mortality at 5 years after implantation compared to pa-
tients who did not develop PTSD [253].
• Type D personality
Patients with type D personality are more likely to develop depres-
sion or anxiety disorder pre-implant because they are more ex-
posed to psychological distress, morbidity and mortality [254,255].
Patients with a younger age, increased depression score at base-
line, and Type D personality were especially prone to experience
PTSD and anxiety symptomatology at 12 months follow-up [244].
• Positive psychological variables
In the WEBCARE study [256], optimism was found to be associated
with less distress, and possibly it helps safeguard mental health in
ICD patients. Increasing optimism might be the way forward to re-
duce long-term distress and impaired health status.
• Neuropsychological disorders
These deficits are more present in ICD patients who have experi-
enced appropriate shocks. Difficulties emerged in the ability to
concentrate, visual attention capacity and short-term memory in-
dependently of age and cultural level. Patients with pre-implant
cognitive deficits have a lower probability of survival [257,258].
In summary, in the opinion of the Panel, from the literature analysis
there emerges moderate evidence of an association between ICD
wearers and the following variables:
• Depression
• Anxiety
• Post-traumatic stress disorder
• Type D personality
• Cognitive deficits
PSYCHOLOGICAL INTERVENTIONS
The detection of elements of psychological involvement and daily
clinical practice both make it clear that there is a pressing need for psy-
chological treatments for these patients. The literature indicates the
effectiveness of:
• Psycho-educational interventions:
Evidence from the literature shows that there is a substantial con-
sensus among different researchers on the importance of inter-
vening at a first level with education on the nature, modes and
goals of action of the device [242,259]
• Individual psychotherapy, in particular CBT:
This is identified as elective treatment and as having a greater de-
gree of efficacy in the treatment of psychopathological symptoms
related to the ICD device [260-262]
• Psychotherapy based on mindfulness:
It can increase self-monitoring capacities, metacognitive skills and
body awareness [263]
• Techniques of muscle relaxation and yoga (if associ-
ated with CBT): [264]
• Support groups and psychological support interventions:
These are effective in reducing anxiety-depressive symptoms
[265], in reinforcing coping strategies and in appropriately recog-
nizing physical signals [266].
• Web-based behavioral intervention:
In a clinical trial of a Web-based behavioral intervention for ICD
patients, the Web-based treatment was not superior to usual care
on the long-term regarding patient reported outcomes. Future
studies are warranted to examine the applicability of blended-care
models and focus on further personalizing the program in order to
increase adherence and improve outcomes. [267].
In the Panel’s opinion, from the literature analysis there emerges:
– strong evidence for the efficacy of psychotherapeutic interven-
tions, prevalently cognitive-behavioral, integrated with techniques
of mindfulness and relaxation
– moderate evidence for the efficacy of psycho-educational interven-
tions, support group interventions and psychological support inter-
ventions
Pulmonary hypertension
Living with a serious illness such as pulmonary hypertension can be
a continuous challenge and requires cognitive, emotional and behav-
ioral adaptation [268,269]. The uncertainty of the disease and the re-
sulting disability can have a profound impact on quality of life [270], in
particular on relationships with others, on cognitive abilities, emotions
and on spirituality. The experience of the disease leads to a reformula-
tion of the self, that the person is not always aware of. Anxiety, depres-
sion, panic attacks [268, 271-273] and sleep disorders [274] are the
most common disturbances. In these patients, often of a young age,
there is also an overlap with issues related to pregnancy.
The analysis of the scant literature available to date permits only to
presume moderate evidence for the association between the following
variables and clinical condition:
• Depression
• Anxiety/panic
• Psychophysiological sleep disorders
PSYCHOLOGICAL INTERVENTIONS
These include the treatment of anxiety, depression, and panic at-
tacks, where needed. Verma et al. [273] suggest a combination of phar-
macotherapy and psychotherapy, in particular CBT. There exist few
studies on psychological interventions in pulmonary hypertension
[275-277]. In particular, attention is focused on the teaching of relax-
ation and slow breathing techniques [275,277].
ECS/ERS guidelines [278] affirm that psychosocial support should
be offered to patients with PAH (level I-C recommendation).
The Panel retains that at present there is no clear evidence of the ef-
ficacy of specific psychological interventions.
Grown-up congenital heart (GUCH)
There is no specific literature on CPR in GUCH patients. Recent re-
ports [279,280] indicate the need for psychosocial support and for the
inclusion of adult congenital cardiac patients in traditional cardiologic
rehabilitation programs, and most studies indicate that there is no re-
lation between diagnosis, physical function or presence of residual
symptoms and worse psychological functioning [281-283].
MODERATE EVIDENCE
• Social factors
Loneliness and absence of social support [281,284], and perceived
economic difficulty [284] are associated to a larger extent with
symptoms of anxiety and depression than the health condition itself.
• Depression and anxiety
Most studies indicate the absence of a relationship between diag-
nosis, physical function or presence of residual symptoms and anx-
iety/depression [281,284-287]; nevertheless GUCH patients wearing
an ICD show higher levels of anxiety [288] and in some studies
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nitive deficits or significant functional limitations. In the real world, on
the other hand, more than 50% of people over 75 years are affected by
a combination of three or more chronic diseases in heterogeneous pat-
terns, the cumulative effect of which is different for each one. It is
therefore essential that the approach to the elderly patient maintain al-
ways a high degree of flexibility with respect to the Guideline recom-
mendations available [299].
In particular, in inpatients aged over 75 years undergoing cardiac re-
habilitation, the rate of prevalence of frailty varies from 10 to 60% de-
pending on the weight of the cardiovascular disease [300], and a re-
cent update of the AHA/ACC has stressed that frailty is a crucial factor
both in prognosis and in planning of the rehabilitative intervention, in
that, if present, it calls for a utterly specific approach with patient-cen-
tered and carefully calibrated interventions, so as to maximize the ben-
efits and minimize the risk of adverse events [301].
Hence, the core element indispensable for a correct approach to the
cardiac patient over 75 years is the distinction between an elderly car-
diac patient and a ‘frail’ elderly cardiac patient. There are several in-
terpretative models of frailty but the most convincing for clinical prac-
tice is that developed by Fried [302] from which stems a working defi-
nition of frailty as an organic syndrome that reflects a condition of re-
duced physiological reserve and of high vulnerability to stressors
[303]. The stressors can be determined by the disease condition, acute
or chronic, or they can be iatrogenic, i.e. secondary to the different in-
terventions, not only surgical and/or pharmacological but also inter-
ventions on lifestyle and on the environment [304]. A recent meta-
analysis highlights how frail cardiac patients, when exposed to such
stressors, are at risk of marked and often disproportionate adverse
events, complications, functional decline, disability and death [305].
Frailty, closely related to comorbidity and disability, is characterized in
its physical component by three or more of the following elements: muscle
weakness, weight loss, slowed gait, fatigue and low levels of physical ac-
tivity [302], but it can also be conditioned by problems of the psychic
sphere (e.g., cognitive deficits or depressive symptoms) which can be as-
sociated to specific alterations of many physiological and biological vari-
ables, such as markers of inflammation, coagulation and metabolism.
STRONG EVIDENCE
• Depression
Depression is a consolidated independent risk factor for cardiovas-
cular disease in the elderly population. A systematic review [306]
and data obtained from the Health and Retirement Study [307]
support a bidirectional association between depression and frailty
which appears to be greater, though not significantly, in women.
• Cognitive deficits
Cognitive impairment, even without reaching the diagnostic cri-
teria of dementia, is high among patients with heart disease aged
over 75 years, and the results from a prospective study based on the
AHA Life’s Simple 7 and incident cognitive impairment [308] show
an association with cardiovascular disease and more generally
with an incorrect lifestyle. However, the cause-effect relationship
between cardiovascular disease and cognitive impairment is very
complex in the over-75 age-group, especially if the patient is frail,
and therefore a highly cautious approach, as personalized as pos-
sible, is necessary for the assessment and intervention.
MODERATE EVIDENCE
• Anxiety
A prospective cohort study conducted on 148 elderly patients [309]
underlined the negative prognostic role of a high preoperative level
of anxiety on postoperative mortality and morbidity. Older patients
using psychiatric interviews previously undetected disorders of
anxiety and depression emerged [285,287]. Furthermore, in heart
disease patients with a high level of anxiety - but only in these pa-
tients - a greater vulnerability has been found for an exaggerated
perception of cardiac symptoms [289].
• Knowledge, representation, and awareness of the disease
The conceptualization and the severity of the disease are difficult
to understand on account of the multifactorial nature of the dis-
ease [290]. Patients generally present a good awareness of treat-
ment and of the need for follow-up. There are, however, difficulties
of understanding related to: the anatomy of the heart defect, fac-
tors contributing to the onset of endocarditis, the impact of
smoking and alcohol, the inheritance of a heart condition [291].
Furthermore, the perceived state of health [281,292] and the im-
position of limits more than the disease condition itself are related
to depressive symptoms, to the psychological well-being pre-inter-
vention and to emotional and behavioral problems.
• Disease management and positive psychological variables
There are no significant differences in terms of psychological func-
tioning between normal healthy subjects and patients with GUCH -
on the contrary, in some cases with GUCH there is a better func-
tioning [282,285,293]. Possible explanations could be related to a
greater sense of coherence in GUCH patients [294] or to the fact
that negation and high achievement motivation could influence
patients in self-report questionnaires to present an image of them-
selves that is socially more desirable [293].
• Gender
Women show greater emotional and behavioral problems than men
in regard to the presence of a surgical scar and in relation to prob-
lems associated with pregnancy [295].
In summary, in the opinion of the Panel, from the literature analysis
there emerges moderate evidence for an association between the fol-
lowing variables and GUCH:
• Social factors
• Depression
• Anxiety
• Knowledge, representation, awareness of the disease
PSYCHOLOGICAL INTERVENTIONS
Concerning psychological interventions in GUCH patients there are
few specialized programs [296] and no published data on psychological
interventions [297,298]. In a recent article analyzing the psychological
needs of patients referred to a psychology service [296], the main psy-
chological concerns were: generalized anxiety, heart condition-related
anxiety, low mood tone, and difficulty in managing a medical condition.
On average, patients received 8 sessions of psychotherapy which con-
sisted of cognitive therapy, relaxation techniques and training in com-
munication skills: 88% of the patients reported a reduction or absence
of psychological distress at the end of the sessions.
The Panel believes that at present there is no clear evidence of the
efficacy of specific psychological interventions.
Older/oldest patients (≥75 years)
The extreme variability of the aging process makes the applicability
of EBM in patients over 75 years of age complex. Moreover, in the clin-
ical trials conducted so far, the number of patients in this age-group is
always very modest and, moreover, their clinical features are poorly
representative of the elderly people in the real world. In fact, they are
patients with a single pathology and who do not show significant cog-
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generally tend to report less symptoms of anxiety; however, when
these symptoms are present, age does not appear to act as medi-
ator between level of anxiety and increased risk of death due to a
cardiac event [304].
• Stress
A recent cohort study with control group [310] highlighted an as-
sociation between death of the partner and a cardiovascular event
in the immediate weeks and months following.
• Social factors
In the frail elderly patient, the data available on the protective ac-
tion of psycho-social resources are still controversial: the results of
the Longitudinal Aging Study Amsterdam [LASA], a population
study conducted on 1665 subjects aged 55 to 85 years, highlighted
an absence of significant interaction between frailty and psycho-
social resources, understood as self-efficacy, emotional and instru-
mental support, with respect to functional decline and mortality at
3 years [311]. These findings suggest that only in the initial stages
of frailty do psycho-social resources exert a protective effect, which
is then lost when the functional decline is very advanced.
MILD EVIDENCE
• Personality factors
The results of a systematic review [312] are interesting regarding
the association between hostility and cardiovascular risk: in pa-
tients aged over 75 years, hostility is not frequent but when it is
present it appears significantly associated with greater body
weight, greater anxiety and depression, a higher tendency to som-
atization and a lower quality of life. This pattern appears to be par-
ticularly sensitive to rehabilitation.
• Health literacy
The AHA statement on secondary prevention in elderly cardiac pa-
tients [304] emphasized the association between health literacy
and clinical condition. In patients over 75 years old, especially if
frail, a careful assessment of the costs and benefits of each single
intervention is necessary: communication with the patient and
caregiver must be as effective as possible and the information must
be given in a manner appropriate to their level of health literacy.
The communication style with patients aged over 75 years must
also take into account that aging is usually associated with sensory
impairment (sight, hearing) and cognitive deficits and also the
caregiver of an elderly patient, if the spouse, may be affected by
sensory impairment [313].
In summary, in the opinion of the Panel, from the literature analysis
there emerges an association between the following variables and car-
diac disease in patients aged over 75 years:
– strong evidence:
• Depression
• Cognitive deficits
– moderate evidence:
• Anxiety
• Stress
• Social factors
– mild evidence:
• Personality factors
• Health literacy
PSYCHOLOGICAL INTERVENTIONS
The limited literature available on patients of this age-group makes
it very hard to define the specific psychological interventions carried
out as part of the rehabilitation program, since the scant available evi-
dence support the global efficacy of cardiac rehabilitation regarding
both the various psycho-social risk factors and the cognitive sphere.
The essential requirement of each intervention is a systematic ap-
proach to the patient, so as to incorporate the full complexity related to
advanced age in every decision made, even if there are no signs of
frailty [301]. Identifying which interventions should not be started or
should be interrupted can be extremely complicated in this patient pop-
ulation, even for the psychologist. Factors to be considered include
quantification of the benefit in terms of reduction of baseline risk com-
pared to the outcome considered, risk of adverse events, and assess-
ment of the expected benefits with respect to life expectancy [299].
Several studies with moderate evidence report comprehensive cardiac
rehabilitation to be effective in reducing depression and of anxiety
[312]. In order to understand the depression/frailty relationship, it is
necessary to weigh carefully the depressive symptoms in terms of their
biological or clinical (cognitive-behavioral) structure: major depression,
strongly biological, is an independent risk factor; a depressive syndrome,
on the contrary, could be the manifestation of difficulty in adapting to the
loss of functional autonomy and/or the age-related decline [306]. In the
latter case, frailty may have caused the depressive syndrome and then
become further aggravated by it. The evidence in support in this regard
has important implications for the selection of the screening tools, for-
mulation of a correct diagnosis and then planning of the intervention.
The Update of the 2013 ACCF/AHA Guidelines [301] underlines the
limited emphasis given so far in the various guidelines to the need to
extend educational interventions, which are defined as extremely rele-
vant, also to patients aged over 75 years, actively involving also their
caregivers. Finally, it should be underlined that the data from a recent
RCT support the effectiveness of cardiac rehabilitation, especially the
physical exercise component, in improving the cognitive profile of pa-
tients over 75 years old, even in the presence of initial decline [314].
In the panel’s opinion, from the literature analysis, as yet still lim-
ited, there emerges:
– moderate evidence for the efficacy of interventions of support for
depression;
– moderate evidence for the efficacy of psycho-educational and man-
agement interventions.
Cardiac patients in palliative care
Recently the concept of “managed death” has replaced that of “good
death” and this important change of paradigm requires all health pro-
fessionals to have a precise orientation and adequate knowledge [315]:
• End of life refers to patients who may die within 12 months, which
ranges from an imminent death perspective (a matter of hours, or
days) to a prolonged terminal condition, which in cardiovascular
terms essentially concerns advanced CHF.
• End of life care includes care provided to family members after the
patient dies.
• In prolonged terminal conditions, there is not always a clear dis-
tinction between being sick and dying.
• The transition to end of life care must take place when treatments
are no longer effective, the burden of symptoms is extremey heavy
and it is necessary to evaluate eventual “disease-exchanging ther-
apies”, i.e. a remodulation of treatments in order to allow greater
therapeutic investment in the more functional aspects in line with
the patient’s preferences.
In the cardiovascular field, the natural history of CHF is charac-
terized by a gradual decline in functional capacity, interrupted by
acute episodes of instability which further worsen the trend. In ad-
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sociated with the patient’s level of dependence during the different
stages of the disease, the caregiver’s numerous duties, the frequency
of hospital admissions, the need to use devices and/or new equipment
[320]. The subjective burden refers to the management of all the neg-
ative emotions that the activity of caregiving elicits and is produced by
the interaction between the characteristics of the patient’s illness and
inherent characteristics ofn the caregiver. In the acute phase of hos-
pitalization, the cardiac event is experienced by the family in a trau-
matic way, in that the family members, including for the most part the
spouse, experience a breakdown of their normal way of life and the
loss of physical integrity of their loved one. The dominant feelings are
fear, anxiety, uncertainty, impotence and loss of control. In the phase
of chronicization of the disease and then in the terminal phase, family
members tend to neglect their own state of health in devoting them-
selves to that of the patient and coping with all the other daily needs.
In all phases of the diseases, the following scenarios represent se-
rious challenges:
• the patient’s neuro-cognitive symptoms create an added burden for
the spouse (321)
• the disease can disturb the couple’s sexuality [322]
• if the caregiving spouse is of a young age, the burden can be worse
due to the greater number of duties and responsibilities towards
other family members, e.g. children and/or parents, and towards
work activity, compared to elderly and retired caregivers [321]
• anxiety, depression and the feeling of loss of control of the family
member hinder the patient’s psychosocial adaptation to the dis-
ease [321]
• the personality traits of low optimism and high neuroticism in the
spousal caregiver are associated with major depressive symptoms
in the patient
• a low level of mutuality in the couple [321] is associated with a
high burden of the family member, negatively affecting the care-
giving, and with a worse health status of the patient
• lack of social support and the presence of economic problems in-
crease the caregiver’s burden [323-325]
Protective factors in all phases of the disease are:
• perception of control and good communication with the healthcare
team [326];
• optimism and marital satisfaction and a supportive coping style of
the partner [327];
• the possibility of having good social support, possibly sharing the
care of the patient with another family member [324, 328];
• the possibility for the couple to receive informative and educa-
tional interventions regarding the area of sexuality, to increase
their knowledge, well-being and help them maintain an intimate
relationship [329].
Below are presented the issues related to the burden in the different
phases of illness.
1) Acute phase of the disease (family caregivers of an
ischemic and/or CABG patient)
Caregiver burden may be due to the demand on time (objective time
spent) and difficulty with caregiving activities (subjective perceived
stress) [330]
• CABG caregivers have reported feeling unprepared for their role
and thus are at risk of caregiver burden. Compared to females,
male CABG caregivers had totally different challenges and per-
ceived the organizing of care as more demanding than females. All
male caregivers have higher demand (time spent), difficulty (level
of stress) and overall burden compared to female caregivers [330]
• Older CABG caregivers (>70 years) are also at risk of greater
burden [330]
vanced CHF, or phase D according to AHA, the high rate of mortality
is hard to modify, the symptoms are disabling and the quality of life
heavily compromised; nevertheless, the prognostic stratification still
remains very difficult. Therefore, selecting patients with advanced
CHF and a high risk of mortality at 1 year, to shift, at the right time,
the goal of treatment from maintenance of life at all costs to allevia-
tion of symptoms and possible improvement in the quality of life re-
quires an integrated approach that takes into account not only the
risk scores but also the clinical opinion of all members in the team.
These patients, characterized by complicated symptoms refractory to
treatment, by a high level of psychological distress, and by a stringent need
to reach shared decisions with their caregivers and family, can benefit
greatly from a palliative care approach. [316,317]. In the advanced phase
of illness, the patient experiences a marked reduction in their quality of
life: from a physical point of view, the symptoms most frequently perceived
are fatigue, dyspnea and edema in the limbs. From a psychological point of
view, uncertainty and fear and a general sense of imminent death prevail.
The sense of threat together with the loss of their family and social role,
the physical limitation and the restriction of will and freedom determine
profound existential changes. From the awareness of imminent death to
the actual death itself, patients go through a series of phases, whose tem-
poral succession varies from individual to individual, during which they
pass from the acute crisis of realization to possible acceptance until the
final phase of withdrawal into themselves [318].
In the panel’s opinion, from the literature analysis, there emerges:
– strong evidence for an association between the following variables
and palliative care in cardiac disease:
• Depression
• Distress
– moderate evidence for the association with:
• Anxiety
• Social factors
– mild evidence for the association with:
• Personality factors
PSYCHOLOGICAL INTERVENTIONS
The statement published in 2012 by the AHA was a real ‘call to action’
on the need to promote a shared decision-making process with the patient
suffering from advanced heart failure [318]. The document illustrates a
sort of road map to guide all team members in the activation of a shared
decision-making process, precisely during the transition phase, i.e. when
the context is increasingly characterized by uncertain prognosis, different
outcomes often “competing” with each other, and communication bar-
riers. It is necessary to maintain attention on the clinical evolution of the
disease, to adjust expectations and to promptly guide decisions; all the
same, uncertainty is unavoidable and needs to be included in discussions
with patients and family members. Discussions with patients must take
into account all the outcomes, not only that of survival but also those of
major adverse events, the burden of symptoms, functional limitations,
loss of independence, quality of life and constraints on caregivers.
In the panel’s opinion, from the literature analysis, as yet still lim-
ited, there emerges strong evidence for:
• Interventions of shared decision making with the patient and
family members
• A palliative care approach
Patient caregiver
In dealing with the topic of caregiving, it is necessary to distinguish
between objective and subjective burden. The objective burden is as-
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• symptoms of PTSD (alarm, hypervigilance, confusion, derealiza-
tion) in the family caregiver have negative effects on the patient’s
disease management [331]
Psychological interventions aimed at ischemic patients and their
partners improve, in the spouse, the anxiety, knowledge, and satisfac-
tion about care [332]. Family members, particularly wives, young care-
givers and with a high educational level, request to participate actively,
together with the patient, in the interventions of secondary prevention
and in the decision-making processes regarding drug treatment and
the change of lifestyle. It is therefore necessary to have interventions
of support centered on the person but aimed at the couple in order to
reduce anxiety and improve communication and coping skills [326].
These interventions must also be focused on topics such as communi-
cation, care, vigilance but also respect for autonomy (family members
frequently assume a ‘controlling’ attitude towards the patient and an
attitude of ‘neglect’ regarding their own needs), changes in family
roles and perspectives/expectations regarding the future [331,333].
In order to change lifestyle, the usefulness of motivational inter-
views with the couple is pointed out - they are effective in identifying
processes that perpetuate dysfunctional behaviors, in exploring pos-
sible alternatives, and in determining the motivation for change,
helping the couple to reflect on the modes of communication (‘sup-
portive’ vs ‘controlling’) and promoting the use of ‘supportive’ commu-
nication strategies, with positive effects on the change of risk behav-
iors for health [334].
2) Chronic phase of illness (family caregivers of a patient
with CHF)
Considering caregiving factors together with patient factors signifi-
cantly increases our understanding of patient clinical events risk in
CHF [335]. The influence of an effective caregiver on CHF patient out-
comes has been shown in improved quality of life, lower hospitalization
rates [335] and reduced mortality. Psychological distress of the spouse
increases the symptoms of heart failure, regardless of the stress per-
ceived by the patient and/or NYHA class [336]. However, providing reg-
ular care to a CHF patient can lead to deficits in the caregiver’s own
health and quality of life. Studies have shown that HF caregivers expe-
rience a similar level of burden as caregivers of patients with advanced
cancer and chronic obstructive pulmonary disease [Humphrey 2013].
The assistance and care of patients with heart failure is perceived as
demanding and characterized by a strong emotional distress with feel-
ings of insecurity and uncertainty, by less personal freedom, experi-
ence of solitude, social isolation and often by economic problems
[325,337]. The literature indicates that the burden is worse in the
presence of certain individual factors and external factors [324].
The main individual dimensions that make caregivers particularly
vulnerable are:
• female gender [324]. Female partners of patients with heart
failure have a lower quality of life compared to male caregivers and
a lower level of well-being in general compared to female partners
of healthy people;
• a low perception of control [324,337,323];
• a low quality of life regarding the physical component [338]: care-
giving worsens the physical health status of family members with
pre-existing health problems.
The main external factors that increase the burden are:
• poor physical and mental health of the patient [324,337,338],
frequent emergency hospitalizations [323,324,338], and difficulty
in managing symptoms and therapies [338]. The most difficult
tasks related to caregiving (monitoring of symptoms, managing
medication and behavioral and food indications) contribute signif-
icantly to worsening the caregiver’s physical health.
The literature regarding interventions for caregivers of patients with
heart failure has focused on management, communication and rela-
tional aspects to improve the patient’s health conditions, as well as on
the disease management, but also on the burden of the caregiver. There
are different modes of intervention according to the different goals:
• interventions involving patients, family and physicians aimed at
improving the patient’s disease management in terms of self-care,
symptoms monitoring and taking of medications [339].
• interventions focused on the family and on reducing the care-
giver’s burden aimed at improving the physical and mental health
of the patient and relational aspects [340].
• interventions of ‘telehealth care’ and ‘telephone coaching’ aimed
at improving management of the transition phase to home [341]
and at increasing the perceived caregiver mastery [342].
3) Family caregivers of patients undergoing heart trans-
plantation
Relatives take on great responsibilities during patients’ heart or lung
transplant process and an understanding of their situation is required.
Any patient for whom social supports are considered insufficient to
achieve compliant care in the outpatient setting may be regarded as
having a relative contraindication to transplant [178]. Research has
shown that relatives of patients wait-listed for HT worry about a rapid
disease progression and death while the patient is waiting for new or-
gans. Most relatives suffer from uncertainty, fear and stress. These emo-
tions persist after the transplantation, during the recovery period, and
in some cases for years because of the risk of acute or, in the longer
term, chronic organ rejection and death [178]. Poor physical health in
the caregiver at 12 months after transplantation results in a lower pa-
tient survival during the next seven years [343]. After HT, considering
the consequences on the psychophysical health and socio-economic
level of caregivers, some authors have identified the need for psycho-
logical support to the family [344] and for psychotherapeutic interven-
tions addressed to the family [345]; others, focusing on potential con-
flicts in the marital relationship, suggest the utility of psychosocial in-
terventions of counseling addressed to the couple [346,347].
4) Family caregivers of patients undergoing implantation
of a device
During the implantation phase, the family lives in a condition of dis-
tress characterized by a physical and emotional burden linked to the
sense of responsibility, fear, anxiety, and loss of freedom and independ-
ence [348,349]. There is a higher level of anxiety in the family members
than in the patients themselves and about 23% of caregivers manifest
PTSD, which is not found in patients [350]. If the LVAD implant was
done in an emergency and, therefore, caregivers and patients could not
receive adequate information, the anxiety and fear remain, especially
for caregivers, even in the period after the implant itself [349].
5) Family caregivers of patients in the terminal phase
There are few systematic studies on the families of cardiac patients
in the terminal phase of illness [351]. The experience of burden ap-
pears to be relatively stable over time, without much differentiation be-
tween the phase of chronic disease and the terminal phase, but in the
terminal phase the family caregiver of a cardiac patient appears to be
characterized by specific needs for information and communication re-
garding palliative care and decisions on the end of life. Some studies
point out that caregivers complain about a lack of information from
care personnel regarding the treatment of symptoms, and of prognostic
information about the future development of the disease, including end
of life issues (e.g., disactivation of ICD), and hence a lack of planning
of the timing and services that can support the patient and caregiver in
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ence of an emotional and social support network, increase their ca-
pacity of adaptation to the caregiver role through specific interventions
that increase the caregiver ‘s own coping strategies and make them
more effective [356]. Indeed, some studies have shown that the expe-
rience of caregiving can be experienced not only as a source of stress
but also as a positive experience [359], especially when the communi-
cation between patient and caregiver is improved, with positive effects
on both the management of the disease and on the quality of life of
both partners [363], placing at the center of interest the concept of the
patient-caregiver dyad [364].
Best practice in psychological activities in CPR
Best practice is defined as those interventions, programs, or strate-
gies that have, through multiple implementation, demonstrated a high
impact (positive changes related to the desired goals, high adaptability,
i.e. successful adaptation and transferability to different settings) and
high quality of evidence (excellent quality of research/evaluation
methodology, confirming the intervention’s high impact and adapt-
ability evidence). Best practice is one that is most suitable given the
available evidence and particular situation or context. In health pro-
motion, such practices are used to demonstrate what works for en-
hancing health-related outcomes of individuals and communities, and
how and why they work in different situations and contexts [from
Canadian Best Practice Portal; accessed on 11 December 2017].
The process of evaluating the goodness of a practice is particularly
critical. The approaches and methodologies can be many and various,
but there will nevertheless always be a component of subjectivity.
The Panel referred to the following factors of relevance:
• performance = ability of a practice to achieve the objectives
(based on data from the literature);
• efficiency and sustainability = ability of a practice to base itself
on existing resources and to make efficient use of these resources;
• transferability/reproducibility = exportability of the practice to
different contexts;
• learning and relationships = ability of the practice to create rela-
tionships and contexts of interdisciplinary learning and collaboration.
By best practice we thus mean a series of general indications of sup-
port for each decision-making node in the assessment and interven-
tion, transversal to the different pathologies, based on analysis of the
evidence as well as on considerations of a legal and deontological na-
ture (Figure 1).
the terminal phase of illness [352]. From the literature there emerges
a sense of frustration regarding the use, in this phase and by the doc-
tors, of technical jargon difficult to understand [353]. From the
analysis of the literature, some considerations emerge:
• young age, female sex and persistent family conflicts are factors asso-
ciated with greater emotional stress experienced by caregivers [354];
• a fatalistic/anxious coping style [355] of the family caregiver
worsens the burden;
• poor social support [354,356], poor help in managing daily activi-
ties [357], and family economic problems [355] worsen the pa-
tient’s disease management;
• an inadequate knowledge/awareness of the terminal status on the
part of the family caregiver interferes with the patient’s disease
management [353];
• the progression of the disease severity increases the limitations in
the social relationships of patient and family and aggravates the
communication difficulties between the partners [353].
Family members of terminal cardiac patients display similar needs to
family members of patients with other terminal diseases; therefore, it
is necessary to extend to this group of patients and families the use of
specialized palliative care services with a multidisciplinary approach,
which must include interventions of psychosocial support and on end-
of-life management of the patient aimed at family members [352,357].
6) Family caregivers of patients over 75 years
The caregivers of patients aged ≥75 years are mostly older women,
wives, often also affected by multiple physical age-related disorders and
they are distinguished from other groups of caregivers by their older
age and consequently greater need for help in daily living activities
[358,359]. The burden in these caregivers means they have need for
help in daily tasks, need for emotional support and a general need for
greater communication with both the patient and the doctors [358).
The experience of burden seems to depend mostly on characteristics of
the caregiver, highlighting their ability to adapt to their own role, their
ability to cope and the quality of the previous relationship with the pa-
tient [360]. Because family members of patients >75 years are often
elderly, the main problems are:
• insufficient knowledge/awareness of the patient’s illness due to
lack of communication with the doctors [358];
• low socio-economic status, poor social support and social isolation [361].
It is essential to focalize interventions on the caregiver in order to
provide them with more information and increase their communica-
tion with healthcare staff and with the patient [362], promote the pres-
pimeEDITRICE
Figure 1. General indications of support for each decision-making node in the assessment and intervention, transversal to the different pathologies.
Best practice
It is necessary to:
• assess the possible presence of psychopathological aspects in the medical history and consider referring the patient to local community services
• investigate the possible presence of previous cognitive deficits
• evaluate the possible presence of depression and anxiety, either reactive or related to the clinical condition
• evaluate the presence/absence of social support
• evaluate the knowledge, awareness, acceptance and management of the disease
• take into account sex, age and ethnic minorities
• evaluate positive, personal and environmental resources and construct interventions aimed at reinforcing them
• evaluate the level of health literacy of the patient and caregiver in order to personalize the informative, educational and communication intervention
• design psychological interventions of low/high intensity based on the problems detected and the working and organizational resources present
• provide counseling to caregivers where problems are detected and/or their need emerges from the patients themselves, the family and/or the multidisciplinary team
• provide counseling on sexuality, where problems arise
• structure all of the psychological activity within the multidisciplinary intervention and in synergy with the team
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Following the literature analysis, we were able to define recommen-
dations, according to the grade of evidence: strong (+++), moderate
(++), mild (+), of low and high intensity evidence based psycholog-
ical/psychotherapeutic interventions (Figure 2).
The figure 3 contains operational cards summarizing the assessment
and intervention recommendations, disease by disease, according to the
grade of evidence: strong (+++), moderate (++), mild (+).
A flow chart is provided showing the path from selection to patient
discharge. The selection phase initiates the care process and fea-
tures the choice of the service by the user or person referring. The
definition of some strategies by the psychologist allows to then guide
the requests of the user or person who has referred the patient, es-
pecially in terms of appropriateness of access to the process of care
(Figure 4).
The figure 5 contains a checklist for the selection of patients to be
referred to the psychologist.
The figure 6 lists the recommended psychological and neuropsycho-
logical tests.
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Figure 2. Low and high intensity evidence based psychological/psychotherapeutic interventions in the different cardiac pathologies.
LOW 
Individual and/or group +++ ♥ +++ +++ ♥ +++ ♥ ♥ ♥ ♥
counseling (from single 
interview to motivational 
interview)
Psycho-educational +++ ++ + ++ Only with
sessions regarding costs and
psychosocial risk benefits
factors, smoking, evaluation
diet, etc.
Multidisciplinary +++ +++ + ++ Only with
sessions regarding costs and
information benefits
and management evaluation
(self-care, 
self-management, 
self-help, telemedicine)
HIGH
Psychotherapy +++ + ++ ++ + +++ ♥ ♥ ♥ ♥
interventions: individual, 
group (stress 
management) or family 
(at least 1/week) *
Multidisciplinary +++ ++ ++ ♥
interventions: evidence
of the need to 
implement a structured 
psychotherapeutic 
intervention 
(cognitive-behavioral 
therapy, motivational, 
mindfulness, etc.)
♥Good practice, as suggested by the Panel ; +++, strong evidence; ++,  moderate evidence; +,  mild evidence; *Italian LEA (essential levels of assistance)
(at least 1 / week) which may include short (within 8 sessions), medium (within 16), long (from 16 to 30).
Pathologies
Interventions
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Figure 3. Operational cards.
To be continued on next page
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Figure 3. Continued from previous page.
To be continued on next page
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Figure 3. Continued from previous page.
To be continued on next page
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Figure 3. Continued from previous page.
To be continued on next page
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Figure 3. Continued from previous page.
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Figure 4. Flow chart showing the path from selection to patient discharge.
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Figure 6. Psychological and neuropsychological tests.
Psychological and neuropsychological screening tests. References and description of the tools are available in www.gicr.it in the
psychological area-tools section
• Anxiety and Depression-Revised [AD-R]
• Hospital Anxiety and Depression Scale [HADS]
• Beck Depression Inventory-2 [BDI-2]
• Patient Health Questionnaire 9 [PHQ-9]
• Generalized Anxiety Disorder 7 [GAD-7]
• Mini Mental State Examination [MMSE]
• Montreal Cognitive Assessment [MoCA]
• Addenbrooke’s Cognitive Examination Revised [ACE-R]
• Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM)
• Distress Scale [DS14, Type D personality]
• MaugerI CaRdiac preventiOn-Questionnaire [MICRO-Q]
• Adherence Schedule in Heart Disease–Brief [ASHiD-R]
• Family Strain Questionnaire [FSQ]
• Disease Impact On Caregiver [DIOC]
Figure 5. Checklist for the selection of patients to be referred to the psychologist.
SELECTION CHECKLIST For each area, assess the presence/absence of the listed problems: it is sufficient to find only one
element to make the psychological intervention necessary.
1) PSYCHOLOGICAL COMORBIDITIES YES  NO 
 Depression (during the last month the patient felt down and hopeless? he lost interest and pleasure in life?) Anxiety
(during the last month the patient has had sudden fears or panic? is frequently unable to stop or control worrying?)
 Post-traumatic stress disorder (during the last month the patient has been exposed to a traumatic event? he suffers from
nightmares or intrusive thoughts?)
 Type D personality factors, Hostility (in general the patient feel anxious, irritable, or depressed? he tends to avoid sharing
his thoughts and feelings with other people?)
2) SPECIFIC PSYCHOLOGICAL ISSUES YES  NO 
 Neuropsychological disorders (the patient is cognitively impaired?)
 Acute or chronic mental stress (the patient refers defeat or other serious life events?)
 Chronic stress at work (the patient refers long working hours, extensive overtime work, high psychological demands,
unfairness and job strain?)
 Problems regarding the area of sexuality 
3) DISEASE MANAGEMENT / SOCIAL ISSUES/ CAREGIVER NEEDS YES  NO 
 Inadequate awareness and acceptance of the disease, inadequate treatment adherence (the patient has impaired illness
awareness and treatment related prejiudices?)
 Social isolation and low socio-economic status (the patient is living alone, in a poor residential area? is isolated and
disconnected from others? He has a low educational level, a low income?)
 Caregiver needs / burden (the caregiver needs information, emotional support? The care of patients is perceived as
demanding and characterized by a strong emotional distress and by economic problems?)
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Conclusions
This paper aims to support all psychologists working with CPR pa-
tients in identifying good practice and disease-specific models of in-
tervention. There is, however, a need to develop new models of re-
search that ‘photograph’ the real world of patients (registers, etc.),
often quite different from the selected populations present in clinical
trials. Some recommendations can be made for future research:
• to use and develop new validated “cross cultural” instruments;
• to promote observational studies (registers) that reflect the ‘real world’;
• to develop RCTs, robustly designed and with adequate follow-up, to
evaluate the efficacy of the psychological/psychotherapeutic thera-
pies described in this position paper on psychological and cardio-
vascular endpoints, focused on specific patient groups (in partic-
ular, women and the elderly);
• to develop research on cardiac patients in palliative care;
• to promote studies to evaluate the dedicated caregiver program
with a large, representative, diversified sample that incorporates
information and resources tailored to the specific concerns and
needs of caregivers, in various age and gender cohorts.
Future research should validate concerns in more diverse samples so
that interventions can be targeted to better support male and female
caregivers in the various age-groups.
According to Richards [7], future large-scale trials testing the effec-
tiveness of psychological therapies are required due to the uncertain-
ties within the evidence. Future trials would benefit from testing the
impact of specific (rather than multifactorial) psychological interven-
tions on patients with CHD, and testing the targeting of interventions
to different patient populations (i.e., people with CHD, with or without
psychopathologies).
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